93 related articles for article (PubMed ID: 20139842)
1. Detection of a mammographically occult invasive lobular breast carcinoma by PET/CT in a patient with lymphoma.
Setlik DE; Joyce JM; Jacobs SA
Clin Nucl Med; 2009 Dec; 34(12):939-40. PubMed ID: 20139842
[No Abstract] [Full Text] [Related]
2. [Positron emission tomography combined with computed tomography overturns the initial treatment plan].
Pecking AP
Rev Prat; 2004 Apr; 54(8):839. PubMed ID: 15274455
[No Abstract] [Full Text] [Related]
3. FDG PET-CT in the management of primary breast lymphoma.
Santra A; Kumar R; Reddy R; Halanaik D; Kumar R; Bal CS; Malhotra A
Clin Nucl Med; 2009 Dec; 34(12):848-53. PubMed ID: 20139815
[TBL] [Abstract][Full Text] [Related]
4. A case of lymphocytic mastopathy requiring differential diagnosis from primary breast lymphoma.
Oba M; Sasaki M; Ii T; Hoso M; Ajisaka H; Matsuki N; Miwa K
Breast Cancer; 2009; 16(2):141-6. PubMed ID: 18769994
[TBL] [Abstract][Full Text] [Related]
5. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Zhao TT; Li JG; Li YM
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
[TBL] [Abstract][Full Text] [Related]
6. Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
Groheux D; Moretti JL; Baillet G; Espie M; Giacchetti S; Hindie E; Hennequin C; Vilcoq JR; Cuvier C; Toubert ME; Filmont JE; Sarandi F; Misset JL
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):695-704. PubMed ID: 18436392
[TBL] [Abstract][Full Text] [Related]
7. FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
Lin EC
Clin Nucl Med; 2006 Dec; 31(12):803-5. PubMed ID: 17117078
[TBL] [Abstract][Full Text] [Related]
8. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
9. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
10. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
11. Synchronous prostate cancer incidentally detected by FDG-PET/CT in staging a patient with newly diagnosed nasopharyngeal cancer.
Hung GU; Hsiung CY; Huang ML; Lin ST
Clin Nucl Med; 2009 Dec; 34(12):962-3. PubMed ID: 20139852
[No Abstract] [Full Text] [Related]
12. Invasive lobular carcinoma in a patient with synchronous ductal carcinoma in situ: detection with MR imaging.
Cooney BS; Orel SG; Schnall MD; Troupin RH
AJR Am J Roentgenol; 1994 Jun; 162(6):1318-20. PubMed ID: 8191990
[No Abstract] [Full Text] [Related]
13. Breast cancer therapy: the role of PET-CT in decision making.
Pons F; Duch J; Fuster D
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):210-23. PubMed ID: 19293769
[TBL] [Abstract][Full Text] [Related]
14. Disseminated tuberculosis masquerading as metastatic breast carcinoma on PET-CT.
Das CJ; Kumar R; Balakrishnan VB; Chawla M; Malhotra A
Clin Nucl Med; 2008 May; 33(5):359-61. PubMed ID: 18431158
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic difficulties in infiltrating lobular breast cancer: value of ultrasonography. 33 cases].
Escolano E; Tournegros JM; Le Marc'Hadour F; Bernard P
J Gynecol Obstet Biol Reprod (Paris); 1997; 26(8):781-8. PubMed ID: 9509318
[TBL] [Abstract][Full Text] [Related]
16. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
[No Abstract] [Full Text] [Related]
17. A case of a fibroadenoma coexisting with an invasive lobular carcinoma in the breast.
Tajima S; Kanemaki Y; Kurihara Y; Okamoto K; Shimamoto H; Okazaki H; Okuda I; Kawahara F; Nakajima Y; Fukuda M; Maeda I
Breast Cancer; 2011 Oct; 18(4):319-23. PubMed ID: 19543793
[TBL] [Abstract][Full Text] [Related]
18. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
19. PET-CT demonstration of extensive muscle metastases from breast cancer.
Liu Y; Ghesani N; Mirani N; Zuckier LS
Clin Nucl Med; 2006 May; 31(5):266-8. PubMed ID: 16622333
[No Abstract] [Full Text] [Related]
20. Invasive lobular breast carcinoma mimicking medullary carcinoma.
Terasaki Y; Sato S; Yoshida H; Iezumi K; Suto A; Takeshita T; Omiya H; Kijima H
Acta Cytol; 1998; 42(3):812-5. PubMed ID: 9622715
[No Abstract] [Full Text] [Related]
[Next] [New Search]
